Physician profile
John E Cosmi
NPI 1558458950
$14,839.32
in general payments reported to CMS, 2019-2025
45 companies · $1,257 in 2025
The $1,257 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,456 · 2020: $1,867 · 2021: $2,315 · 2022: $2,391 · 2023: $2,518 · 2024: $2,036 · 2025: $1,257.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,795 · Consulting Fee: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,795.39 |
| Consulting Fee | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $1,861.99 | 2019-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $1,281.04 | 2019-2025 | |
| Boston Scientific Corporation | $1,219.51 | 2019-2025 | Watchman Flx, Watchman Access System, Watchman |
| Janssen Pharmaceuticals, INC | $804.41 | 2019-2023 | Xarelto |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $781.25 | 2019-2025 | Lifevest |
| Amarin Pharma, INC. | $727.74 | 2019-2023 | |
| Sanofi-Aventis U.S. LLC | $725.42 | 2019-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $722.95 | 2019-2025 | Jardiance |
| Pfizer INC. | $596.57 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $595.70 | 2021-2025 | Verquvo, Capvaxive |
| Astrazeneca Pharmaceuticals Lp | $568.39 | 2019-2025 | Farxiga |
| Arbor Pharmaceuticals, INC. | $528.49 | 2019-2021 | |
| E.R. Squibb & Sons, L.L.C. | $467.71 | 2019-2025 | Camzyos, Eliquis |
| Novo Nordisk INC | $431.64 | 2022-2025 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $397.17 | 2020-2025 | Thoratec Heartmate 3 Lvas Implant Kit, Cardiomems, Ensite |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $358.72 | 2023-2025 | Hillrom - Cardiac Ambulatory Monitor, Hillrom - Carnation Ambulatory Monitor |
| Kowa Pharmaceuticals America, INC. | $357.29 | 2019-2024 | Livalo |
| Irhythm Technologies, INC. | $326.71 | 2021-2024 | Zio Xt Patch, Zio Monitor |
| Kestra Medical Technology Services, INC. | $235.74 | 2024-2025 | Assure Wcd |
| Regeneron Healthcare Solutions, INC. | $194.66 | 2019-2023 | Evkeeza |
| Esperion Therapeutics, INC. | $184.08 | 2021-2024 | Nexletol |
| Alnylam Pharmaceuticals INC. | $169.54 | 2020-2025 | Onpattro |
| Cvrx, INC. | $148.85 | 2024-2025 | Barostim Neo System |
| Heartflow, INC. | $137.02 | 2023-2025 | Ffrct |
| Impulse Dynamics (USA) INC. | $130.83 | 2022-2024 | Optimizer, Optimizer |
| Biosense Webster, INC. | $116.33 | 2019-2023 | Carto 3 |
| Kiniksa Pharmaceuticals, Ltd. | $103.94 | 2022-2023 | Arcalyst |
| Bardy Diagnostics, INC. | $80.00 | 2020-2021 | |
| Scpharmaceuticals INC. | $77.63 | 2024 | |
| Lundbeck LLC | $75.83 | 2019-2021 | |
| Althera Pharmaceuticals LLC | $64.44 | 2021-2022 | |
| Azurity Pharmaceuticals, INC. | $48.47 | 2024-2025 | Edarbyclor, Edarbi |
| Philips North America LLC | $45.57 | 2024 | (5044) Mcot |
| Atricure, INC. | $40.41 | 2021-2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $37.86 | 2021-2025 | |
| Kiniksa Pharmaceuticals International, Plc | $34.50 | 2024 | Arcalyst |
| Medicure Pharma INC. | $26.62 | 2021 | |
| Inspire Medical Systems, INC. | $23.01 | 2023 | Inspire |
| Angiodynamics, INC. | $21.64 | 2023 | Auryon Laser System 100-120 Vac |
| Medicomp INC | $19.13 | 2019 | |
| Lexicon Pharmaceuticals, INC. | $19.00 | 2024 | |
| Lilly USA, LLC | $14.71 | 2024 | Zepbound |
| Amryt Pharma Holdings Ltd | $13.33 | 2021 | |
| Abiomed | $12.03 | 2019 | |
| Allergan, INC. | $11.45 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Cosmi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.